drugset / Trial / NCT05315661
The Safety and The Efficacy Evaluation of ET-STEM in Patients With Frontotemporal Dementia
NaSingle-groupOpen-labelTreatment
Summary
The primary purpose of this study is to evaluate the safety and the tolerability of 3 repeated doses of ET-STEM (Mesenchymal stem cells preconditioned with ethionamide) in patients with FTD.
Timeline
- Start
- 2022-07-06
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ET-STEM | Cell therapy | 3e+07 cells | Other |